You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):擬放棄索元生物股權優先受讓權
格隆匯 07-28 17:15

格隆匯7月28日丨仙琚製藥(002332.SZ)公佈,索元生物醫藥(杭州)有限公司(“索元生物”)系公司的參股公司,公司持有其9.9386%的股權。

公司2020722收到索元生物關於股東股權轉讓的通知,索元生物股東廣州越秀金蟬股權投資基金合夥企業(有限合夥)(“越秀金蟬”)持有索元生物注冊資本267.36萬元人民幣(對應2.6840%股權),越秀金蟬4000萬元人民幣的轉讓價格,將其所持有的索元生物註冊資本146.148萬元人民幣(對應1.4672%股權)分別轉讓給杭州三花弘道投資管理合夥企業(有限合夥)與珠海千行智源投資合夥企業(有限合夥)。其中,註冊資本73.074萬元(對應0.7336%股權)以2000萬元人民幣的轉讓價格轉給杭州三花弘道投資管理合夥企業(有限合夥);註冊資本73.074元(對應0.7336%股權)以2000萬元人民幣的轉讓價格轉給珠海千行智源投資合夥企業(有限合夥)。

針對越秀金蟬的股權轉讓,公司結合實際經營發展定位放棄上述股權轉讓的優先受讓權

公司此次放棄索元生物股權優先受讓權不構成關聯交易,也不構成《上市公司重大資產重組管理辦法》規定的上市公司重大資產重組。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account